HER-2 POSITIVE GASTRIC CANCER

HER-2 POSITIVE GASTRIC CANCER was reported 5 times

HER-2 POSITIVE GASTRIC CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
1 Orexin Receptor Antagonist [EPC] 1 0.0001
2 HER2/neu Receptor Antagonist [EPC] 1 0.0000
3 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
4 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 2 0.0000
6 Microtubule Inhibitor [EPC] 1 0.0000
7 Opioid Agonist [EPC] 1 0.0000
8 Platelet Aggregation Inhibitor [EPC] 1 0.0000
9 Proton Pump Inhibitor [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000